Cross-priming of T cells to intracranial tumor antigens elicits an immune response that fails in the effector phase but can be augmented with local immunotherapy
Year: 2006
Type: article
Source: Journal of Neuroimmunology
Institution: University of Chicago
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
Funder: University of Chicago
OpenAlex ID: W1996083409
